Juárez-Villegas LE, Zapata-Tarrés M, Lezama VP, Palomo-Collí MÁ

Language: Spanish
References: 12
Page: 543-547
PDF size: 296.50 Kb.

ABSTRACT

Background. Pierre-Robin Sequence (PRS) is a congenital disease characterized by micrognatia, glosoptosis and U-shaped posterior cleft palate. Its prevalence is 1:8500 newborns. Hepatoblastoma (HB) is the most frequent hepatic malignant tumor in childhood and affects patients ‹3 years of age.
Case report. A 2-year old male with PRS was diagnosed with HB. The boy was the product of the second full term pregnancy. He was born by cesarean with a birth weight of 2750 g. The patient presented with a 1-month history of abdominal mass. Diagnosis of HB was done by biopsy. The patient received chemotherapy with cisplatin, vincristin and 5-fluorouracil as well as left lobectomy. Five years later he is alive without tumor activity.
Conclusions. PRS and HB association has not been reported in the literature. Both entities have chromosome 2 alterations. Because cancer is associated with cytogenetic alterations, future considerations must be made to find a relationship between cancer patients and other genetic entities. This will be useful for finding molecular targets. We can also detect the at-risk population in order to create follow-up programs that will allow an early diagnosis with an improved better survival. It is the first case of PRS and HB reported in either the national or international literature.

REFERENCES

1. Arancibia C. Secuencia de Pierre Robin. Neumol Pediatr 2006;1:34-36.

2. Perilongo G, Shafford E. Liver tumours. Eur J Cancer 1999;35:953-958.

3. Herrera JM, Krebs A, Harris P, Barriga F. Childhood tumors. Surg Clin North Am 2000;80:747-760.

4. DeBaun M, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiedermann Syndrome Registry. J Pediatr 1998;132:398-400.

5. Linet S, Ries L, Smith MA, Tarone RE, Devesa SS. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 1999;91:1051-1058.

6. Darbari A, Sabin KM, Shapiro CN, Schwarz KB. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology 2003;38:560-566.

7. Garber JE, Li FP, Kingston JE, Krush AJ, Strong LC, Finegold MJ, et al. Hepatoblastoma and familial adenomatous polyposis. J Natl Cancer Inst 1988;80:1626-1628.

8. Dasouki M, Barr M Jr. Trisomy 18 and hepatic neoplasia. Am J Med Genet 1987;27:203-205.

9. Mamlok V, Nichols M, Lockhart L, Mamlok R. Trisomy 18 and hepatoblastoma. Am J Med Genet 1989;33:125-126.

10. Tomlinson GE, Douglass EC, Pollock BH, Finegold MJ, Schneider NR. Cytogenetic evaluation of a large series of hepatoblastomas: numerical abnormalities with recurring involving 1q12-21. Genes Chomosomes Cancer 2005;44:177-184.

11. Aggarwal S, Kumar A. Fetal hydrocolpos leading to Pierre Robin sequence: an unreported effect of oligohydramnios sequence. J Perinatol 2003;23:76-78.

12. Sheffeld LJ, Reiss JA, Strohm K, Gilding M. A genetic follow-up study of 64 patients with Pierre Robin complex. Am J Med Genet 1987;28:25-36.